Recent Updates
Recently added Catalysts
PVLA

Palvella Therapeutics Completes $45 Million Series C Financing

Thursday, May 28, 2020 1 min read
Key Takeaway: Palvella Therapeutics Completes $45 Million Series C Financing

Full Press Release Details

Palvella Therapeutics Completes $45 Million Series C Financing.
Tags: PVLA Viatris Investor Conferences Healthcare investor conferences healthcare conferences UBS Global Healthcare
Last updated: May 28, 2020